These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 18220787

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis.
    Bunimov N, Laneuville O.
    Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):268-77. PubMed ID: 19075637
    [Abstract] [Full Text] [Related]

  • 24. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K.
    Wien Klin Wochenschr; 2001 Aug 16; 113(15-16):558-65. PubMed ID: 11571832
    [Abstract] [Full Text] [Related]

  • 25. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.
    Amer M, Bead VR, Bathon J, Blumenthal RS, Edwards DN.
    Cardiol Rev; 2010 Aug 16; 18(4):204-12. PubMed ID: 20539104
    [Abstract] [Full Text] [Related]

  • 26. NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?
    Eras J, Perazella MA.
    Am J Med Sci; 2001 Mar 16; 321(3):181-90. PubMed ID: 11269794
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An evidence-based evaluation of the gastrointestinal safety of coxibs.
    Bombardier C.
    Am J Cardiol; 2002 Mar 21; 89(6A):3D-9D. PubMed ID: 11909555
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.
    das Chagas Pereira de Andrade F, Mendes AN.
    Sci Rep; 2020 Oct 01; 10(1):16204. PubMed ID: 33004893
    [Abstract] [Full Text] [Related]

  • 32. A receptor-grounded approach to teaching nonsteroidal antiinflammatory drug chemistry and structure-activity relationships.
    Roche VF.
    Am J Pharm Educ; 2009 Dec 17; 73(8):143. PubMed ID: 20221336
    [Abstract] [Full Text] [Related]

  • 33. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
    Jiménez P, García A, Santander S, Piazuelo E.
    Curr Pharm Des; 2007 Dec 17; 13(22):2261-73. PubMed ID: 17691999
    [Abstract] [Full Text] [Related]

  • 34. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
    Shamsudin Y, Gutiérrez-de-Terán H, Åqvist J.
    Biochemistry; 2018 Feb 20; 57(7):1236-1248. PubMed ID: 29345921
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Progress in COX-2 inhibitors: a journey so far.
    Chakraborti AK, Garg SK, Kumar R, Motiwala HF, Jadhavar PS.
    Curr Med Chem; 2010 Feb 20; 17(15):1563-93. PubMed ID: 20166930
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA, Khan NK.
    Exp Toxicol Pathol; 2006 Nov 20; 58(2-3):163-73. PubMed ID: 16859903
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases.
    Ferrer MD, Busquets-Cortés C, Capó X, Tejada S, Tur JA, Pons A, Sureda A.
    Curr Med Chem; 2019 Nov 20; 26(18):3225-3241. PubMed ID: 29756563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.